To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DFFATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
507 supporting clones for gene DFFA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA904332   .a 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DA048901   .a 8 to 562 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BP192846 brain .a 21 to 602 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN282660 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 21 to 449 28 to 456       429/456
(94 %)
6 diff
(98.7 %id)
DA694043   .a 24 to 594 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
NM_004401.2   .a 27 to 2062 1 to 2036 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2036/2036
(100 %)
0 diff
(100 %id)
BP297176   .a 36 to 616 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BP366460 thymus .a 36 to 614 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BP254697 Kidney .a 39 to 620 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA060195 cerebellum .a 40 to 589 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA475899   .a 40 to 620 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BQ880975 brain, neuroblastoma, cell line .a 53 to 620 1 to 573       573/998
(57 %)
12 diff
(98.8 %id)
BX427315 fetal liver, Liver .a 54 to 917 1 to 864   fully sequenced,   864/864
(100 %)
6 diff
(99.4 %id)
BG031298 breast, mammary adenocarcinoma, cell line .a 54 to 633 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA343150 substantia nigra .a 55 to 600 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA476110   .a 55 to 600 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
BC007112 skeletal muscle .a 56 to 1526 1 to 1471 exact available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1471/1471
(100 %)
2 diff
(99.9 %id)
AL703013 human skeletal muscle .a 56 to 610 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BP272073   .a 56 to 658 1 to 603       603/603
(100 %)
4 diff
(99.4 %id)
DA006297   .a 57 to 617 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP281559 bone marrow .a 57 to 643 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
DA438970 tongue, tumor tissue .a 58 to 660 2 to 605   capped   604/604
(100 %)
2 diff
(99.7 %id)
DA553440   .a 60 to 591 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA605901   .a 60 to 606 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BP328543 rectum .a 61 to 641 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA067444 cerebellum .a 62 to 600 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA519615 brain .a 62 to 600 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA609468   .a 62 to 624 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA789109 brain .a 62 to 648 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BF204783 muscle, rhabdomyosarcoma .a 69 to 591 1 to 526       526/1212
(43 %)
13 diff
(99.0 %id)
U91985   .a 69 to 1683 1 to 1615 exact AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1615/1615
(100 %)
1 diff
(100.0 %id)
BI261849 lymph, lymphoma, cell line .a 70 to 728 1 to 659       659/659
(100 %)
2 diff
(99.7 %id)
BQ059183 lymph, lymphoma, cell line .a 70 to 1089 32 to 1064       1033/1096
(94 %)
39 diff
(96.5 %id)
BQ063251 lymph, lymphoma, cell line .a 74 to 1020 1 to 959       959/1031
(93 %)
23 diff
(97.8 %id)
BI258629 cervical carcinoma cell line, cervix .a 79 to 928 1 to 857       857/857
(100 %)
17 diff
(98.1 %id)
CN282658 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 84 to 418 1 to 335       335/335
(100 %)
0 diff
(100 %id)
CB124665 Liver .a 89 to 373 1 to 285       285/285
(100 %)
4 diff
(98.6 %id)
CB124221 Liver .a 89 to 588 1 to 500       500/500
(100 %)
0 diff
(100 %id)
DA611272   .a 90 to 631 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
AK222546 coronary artery .a 91 to 1668 1 to 1578 G101E     1578/1578
(100 %)
2 diff
(99.9 %id)
BP202932 coronary artery .a 91 to 672 1 to 582       582/582
(100 %)
13 diff
(97.8 %id)
AU128960   .a 92 to 645 2 to 557   capped   556/556
(100 %)
8 diff
(98.6 %id)
BP870759 embryonal kidney .a 93 to 422 1 to 329       329/332
(99 %)
3 diff
(99.1 %id)
AA332520 Embryo, 8 weeks .a 93 to 379 1 to 289       289/302
(95 %)
4 diff
(98.7 %id)
AK313317 breast, tumor tissue .a 93 to 1120 1 to 1028 exact     1028/1028
(100 %)
1 diff
(100.0 %id)
BM761931 myeloma .a 93 to 598 1 to 506       506/506
(100 %)
0 diff
(100 %id)
DA999212 breast, tumor tissue .a 94 to 649 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BC007721 Eye, normal, pigmented retinal epithelium .a 95 to 2062 1 to 1967 R291W tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1967/1967
(100 %)
4 diff
(99.8 %id)
BG469236 adenocarcinoma cell line, colon .a 103 to 681 1 to 607       607/719
(84 %)
35 diff
(95.2 %id)
BG829359 muscle, rhabdomyosarcoma .a 103 to 652 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
BM912803 amelanotic melanoma, cell line, skin .a 105 to 1043 1 to 954       954/1084
(88 %)
30 diff
(97.3 %id)
BC000037 Kidney, renal cell adenocarcinoma .a 107 to 1683 1 to 1577 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1577/1577
(100 %)
0 diff
(100 %id)
CN282647 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 107 to 614 12 to 519       508/519
(97 %)
6 diff
(98.9 %id)
BG826135 muscle, rhabdomyosarcoma .a 107 to 674 1 to 578       574/578
(99 %)
26 diff
(95.6 %id)
BG826322 muscle, rhabdomyosarcoma .a 107 to 1006 1 to 899       899/930
(96 %)
26 diff
(97.3 %id)
BM916418 amelanotic melanoma, cell line, skin .a 107 to 1116 1 to 1015       1013/1104
(91 %)
21 diff
(98.1 %id)
BU855912 ovary, teratocarcinoma, cell line .a 107 to 1020 1 to 922       922/927
(99 %)
19 diff
(98.0 %id)
AA357757 Prostate .a 108 to 253 1 to 146       146/146
(100 %)
0 diff
(100 %id)
BF203854 muscle, rhabdomyosarcoma .a 108 to 626 531 to 16     Submitted on the opposite strand 516/780
(66 %)
3 diff
(99.7 %id)
BF308270 muscle, rhabdomyosarcoma .a 108 to 626 533 to 16     Submitted on the opposite strand 518/964
(53 %)
1 diff
(99.9 %id)
AA100177 Pancreas .a 109 to 251 1 to 146       146/146
(100 %)
4 diff
(97.3 %id)
BQ647145 hepatocellular carcinoma, cell line, Liver .a 109 to 1013 1 to 909       909/928
(97 %)
26 diff
(97.2 %id)
BM917078 blood, natural killer cells, cell line .a 110 to 1187 1 to 1089 E218X A244X L245T R246E E247G ...     1089/1089
(100 %)
53 diff
(95.2 %id)
BU195842 leiomyosarcoma, uterus .a 110 to 983 1 to 888       884/899
(98 %)
19 diff
(97.9 %id)
BU176366 eye, retinoblastoma .a 111 to 974 1 to 871       871/884
(98 %)
14 diff
(98.5 %id)
BM458163 leiomyosarcoma, uterus .a 112 to 966 1 to 862       862/982
(87 %)
12 diff
(98.8 %id)
BQ716291 sympathetic trunk .a 115 to 992 1 to 886       886/913
(97 %)
13 diff
(98.6 %id)
BE311859 Kidney, renal cell adenocarcinoma .a 123 to 642 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
TI_1948075778   .a 123 to 634 125 to 638       514/1358
(37 %)
32 diff
(97.7 %id)
BT006980   .a 125 to 1120 1 to 996 exact     996/996
(100 %)
0 diff
(100 %id)
CV026884 mixed .a 125 to 643 1 to 519       519/519
(100 %)
0 diff
(100 %id)
TI_1948075501   .a 125 to 699 127 to 702       576/1048
(54 %)
26 diff
(97.6 %id)
TI_1948076048   .a 125 to 1119 127 to 1122       994/1285
(77 %)
53 diff
(95.9 %id)
CX166048 human embryonic stem cells differentiated toan early endodermal cell type .a 136 to 917 1 to 782       782/782
(100 %)
0 diff
(100 %id)
CN282657 embryonic stem cells, cell lines H1, H7, andH9 .a 155 to 421 1 to 267       267/267
(100 %)
2 diff
(99.3 %id)
BQ893613 ductal carcinoma, cell line, Pancreas .a 155 to 1033 1 to 888       888/888
(100 %)
20 diff
(97.8 %id)
BQ061278 lymph, lymphoma, cell line .a 172 to 1177 1 to 1012       1012/1012
(100 %)
17 diff
(98.4 %id)
CX786955 human embryonic stem cells .a 188 to 963 1 to 775       775/775
(100 %)
3 diff
(99.7 %id)
TI_1948075504   .a 259 to 1119 979 to 131       849/1133
(74 %)
19 diff
(98.4 %id)
TI_1948075203   .a 262 to 1119 987 to 128   AAA   860/1141
(75 %)
34 diff
(97.1 %id)
BI223680 cervical carcinoma cell line, cervix .a 341 to 1113 1 to 772       772/776
(99 %)
2 diff
(99.8 %id)
BG392294 embryonal carcinoma, cell line, testis .a 349 to 1162 1 to 803       802/1003
(79 %)
30 diff
(97.1 %id)
TI_1948075503   .a 350 to 1119 899 to 123       777/1442
(53 %)
22 diff
(98.5 %id)
BE297489 muscle, rhabdomyosarcoma .a 366 to 1031 26 to 689       664/689
(96 %)
9 diff
(98.7 %id)
BE300366 muscle, rhabdomyosarcoma .a 378 to 972 47 to 637       591/637
(92 %)
12 diff
(98.2 %id)
BF972631 leiomyosarcoma cell line, uterus .a 403 to 1176 1 to 770       770/941
(81 %)
20 diff
(97.9 %id)
BG338066 leiomyosarcoma cell line, uterus .a 404 to 1228 1 to 825       825/1005
(82 %)
22 diff
(97.9 %id)
TI_1948076049   .a 419 to 1119 826 to 124       703/1383
(50 %)
10 diff
(99.3 %id)
TI_1948076050   .a 419 to 1119 824 to 127       698/1104
(63 %)
14 diff
(98.8 %id)
AL555932 placenta .a 435 to 1317 1 to 884       884/884
(100 %)
1 diff
(99.9 %id)
BI868763 adenocarcinoma, cell line, Liver .a 443 to 1153 1 to 710       710/710
(100 %)
4 diff
(99.5 %id)
TI_57227656   .a 443 to 1153 46 to 755       710/710
(100 %)
4 diff
(99.5 %id)
TI_154171135   .a 444 to 996 96 to 648       553/553
(100 %)
0 diff
(100 %id)
BQ051769 blood, natural killer cells, cell line .a 447 to 1382 1 to 939       939/945
(99 %)
14 diff
(98.6 %id)
DN601717 human embryonic stem cells .a 474 to 1168 1 to 695       695/695
(100 %)
0 diff
(100 %id)
CB114843 Liver .a 477 to 976 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BI115576 lung, small cell carcinoma .a 502 to 1417 1 to 916       916/947
(96 %)
42 diff
(95.6 %id)
BQ961986 epithelioid carcinoma cell line, Pancreas .a 521 to 1369 1 to 862       862/918
(93 %)
14 diff
(98.5 %id)
TI_1948075780   .a 564 to 1119 685 to 130       556/1137
(48 %)
10 diff
(99.2 %id)
BI259011 cervical carcinoma cell line, cervix .a 570 to 1231 1 to 661       661/661
(100 %)
4 diff
(99.4 %id)
TI_1948075779   .a 576 to 1119 672 to 125       548/1470
(37 %)
20 diff
(98.7 %id)
BG750846 eye, normal pigmented retinal epithelium .a 584 to 1294 1 to 710       710/713
(99 %)
4 diff
(99.5 %id)
CB242099 Human Lung Epithelial cells, lung .a 638 to 1341 718 to 16   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 703/703
(100 %)
1 diff
(99.9 %id)
AW024903 Kidney .a 644 to 1382 739 to 1       737/739
(99 %)
14 diff
(98.2 %id)
DW407979 Liver .a 677 to 1112 16 to 451       436/451
(96 %)
7 diff
(98.5 %id)
AA310605   .a 723 to 999 24 to 300       277/300
(92 %)
9 diff
(97.0 %id)
AU151171   .a 769 to 1341 568 to 1       568/568
(100 %)
24 diff
(95.8 %id)
BU199219   .a 771 to 1259 48 to 538       491/674
(72 %)
33 diff
(95.2 %id)
BU195506 eye, retinoblastoma .a 793 to 1645 1 to 865       865/915
(94 %)
14 diff
(98.5 %id)
TI_149285852   .a 820 to 1526 793 to 85   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 709/709
(100 %)
8 diff
(98.9 %id)
AI337389 colon, colon tumor, RER+ .a 841 to 1386 549 to 4       546/551
(99 %)
2 diff
(99.7 %id)
BU556879 ovary, teratocarcinoma, cell line .a 846 to 1717 1 to 880   tiling clone, AAA   880/941
(93 %)
18 diff
(98.1 %id)
BQ005589 Chondrosarcoma, Left Pelvis .a 848 to 1382 552 to 19   AAA   534/534
(100 %)
1 diff
(99.9 %id)
BI262373 lymph, lymphoma, cell line .a 862 to 1632 783 to 1       783/1045
(74 %)
17 diff
(98.4 %id)
BX427314 fetal liver, Liver .a 877 to 1352 479 to 1   fully sequenced,   479/479
(100 %)
3 diff
(99.4 %id)
BM465810 eye, retinoblastoma .b 1 to 881 1 to 891 L206X E207G L208V V209G T210Y ... tiling clone,   891/1031
(86 %)
31 diff
(97.0 %id)
DT218953 brain .c 1 to 716 1 to 716   tiling clone,   716/716
(100 %)
0 diff
(100 %id)
AU118843 whole embryo, mainly head .c 1 to 729 2 to 730   capped   729/770
(94 %)
3 diff
(99.7 %id)
NM_213566.1   .c 1 to 3391 1 to 3391 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3391/3391
(100 %)
0 diff
(100 %id)
AU121791 mammary gland .c 2 to 729 2 to 729   capped   728/815
(89 %)
3 diff
(99.7 %id)
AU117274 whole embryo, mainly head .c 11 to 729 2 to 720   capped   719/722
(99 %)
6 diff
(99.2 %id)
BF571553 melanotic melanoma, high MDR, skin .c 12 to 727 1 to 728       728/1090
(66 %)
57 diff
(94.8 %id)
DA292434 hippocampus .c 13 to 261 2 to 250   capped   249/249
(100 %)
0 diff
(100 %id)
AU102994   .c 13 to 62 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
CB988677 Human Placenta, placenta .c 13 to 701 28 to 722       693/795
(87 %)
21 diff
(97.4 %id)
DB251112 uterus .c 14 to 529 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
BE899412 adenocarcinoma cell line, ovary .c 18 to 647 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
CD710002 normal nasopharynx .c 20 to 119 7 to 107       101/107
(94 %)
6 diff
(94.4 %id)
BG822484 adenocarcinoma cell line, colon .c 20 to 539 1 to 530       530/745
(71 %)
17 diff
(97.8 %id)
CN282661 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 26 to 755 1 to 733       733/742
(98 %)
3 diff
(99.6 %id)
CD697944 normal nasopharynx .c 27 to 522 35 to 530       496/530
(93 %)
7 diff
(98.7 %id)
BF212577 bone marrow, from chronic myelogenous leukemia .c 27 to 704 1 to 684       684/922
(74 %)
53 diff
(94.3 %id)
BG723577 testis .c 27 to 916 1 to 888 L199W E200R K201Q E202R G203A ...     888/892
(99 %)
36 diff
(96.0 %id)
BG722608 testis .c 27 to 727 1 to 699       699/722
(96 %)
8 diff
(98.9 %id)
BG772127 testis .c 27 to 729 1 to 702       702/811
(86 %)
9 diff
(98.9 %id)
BM471458 melanotic melanoma, skin .c 27 to 849 1 to 831       831/1009
(82 %)
12 diff
(98.9 %id)
BQ950940 large cell carcinoma, lung .c 27 to 726 1 to 700       700/930
(75 %)
4 diff
(99.6 %id)
BU528010 epidermoid carcinoma, cell line, lung .c 27 to 922 24 to 926 C165R V223X L245P R246E E247G ...     903/926
(97 %)
17 diff
(98.2 %id)
DA082329 cerebellum .c 29 to 517 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
BU552870 ovary, teratocarcinoma, cell line .c 29 to 885 1 to 859       859/914
(93 %)
20 diff
(97.9 %id)
DR760339 embryonic stem .c 29 to 833 1 to 805       805/805
(100 %)
0 diff
(100 %id)
BQ718041 sympathetic trunk .c 34 to 729 1 to 704       704/938
(75 %)
14 diff
(98.6 %id)
BU191708 epidermoid carcinoma, cell line, salivary gland .c 37 to 782 1 to 751       751/939
(79 %)
18 diff
(98.1 %id)
BF309422 muscle, rhabdomyosarcoma .c 39 to 759 1 to 716       716/742
(96 %)
8 diff
(99.0 %id)
CR995839 T-Lymphocytes .c 39 to 748 1 to 711       711/712
(99 %)
2 diff
(99.8 %id)
BG744264 blood, natural killer cells, cell line .c 41 to 706 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
CN282652 embryonic stem cells, cell lines H1, H7, andH9 .c 42 to 748 1 to 707       707/707
(100 %)
2 diff
(99.8 %id)
BE514633 adenocarcinoma cell line, ovary .c 43 to 727 1 to 682       682/786
(86 %)
11 diff
(98.7 %id)
BF305677 muscle, rhabdomyosarcoma .c 43 to 729 1 to 687       687/718
(95 %)
7 diff
(99.1 %id)
BF663119 B-cells, primary B-cells from tonsils (cell line) .c 43 to 756 1 to 707       707/708
(99 %)
12 diff
(98.4 %id)
BG685820 B-cells, primary B-cells from tonsils (cell line) .c 43 to 769 1 to 730       730/731
(99 %)
7 diff
(99.1 %id)
BG759292 B-cells, primary B-cells from tonsils (cell line) .c 43 to 688 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
BG757484 B-cells, primary B-cells from tonsils (cell line) .c 43 to 885 1 to 861       859/877
(97 %)
32 diff
(96.4 %id)
BG765207 melanotic melanoma, high MDR (cell line), skin .c 43 to 817 1 to 781       781/781
(100 %)
10 diff
(98.8 %id)
BG829188 muscle, rhabdomyosarcoma .c 43 to 892 1 to 852       852/897
(94 %)
11 diff
(98.8 %id)
BQ063532 lymph, lymphoma, cell line .c 48 to 807 1 to 766       766/1057
(72 %)
9 diff
(99.2 %id)
CR596851 Neuroblastoma Cot 25-normalized .c 49 to 1439 1 to 1391 exact     1391/1391
(100 %)
0 diff
(100 %id)
AL527313 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 49 to 760 1 to 712   fully sequenced,   712/712
(100 %)
1 diff
(99.9 %id)
BG107353 lymph, lymphoma, cell line .c 50 to 645 13 to 612       600/1086
(55 %)
14 diff
(98.8 %id)
DB466235 hippocampus .c 51 to 482 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
CN282651 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 52 to 834 1 to 783       783/783
(100 %)
2 diff
(99.8 %id)
BE019047 muscle, rhabdomyosarcoma .c 54 to 662 1 to 608       608/608
(100 %)
4 diff
(99.4 %id)
DA686976   .c 57 to 603 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
BP332525 renal proximal tubule .c 57 to 639 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CD706690 normal nasopharynx .c 58 to 522 41 to 508       468/508
(92 %)
7 diff
(98.7 %id)
DA194434 amygdala .c 59 to 650 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BU187408 eye, retinoblastoma .c 59 to 756 1 to 698       698/873
(79 %)
7 diff
(99.2 %id)
BE294665 muscle, rhabdomyosarcoma .c 60 to 530 1 to 472       472/474
(99 %)
2 diff
(99.6 %id)
DA430903 colon .c 61 to 574 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA448225 tongue, tumor tissue .c 61 to 601 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA477434   .c 61 to 645 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BE299747 muscle, rhabdomyosarcoma .c 61 to 838 1 to 776       776/776
(100 %)
6 diff
(99.3 %id)
DA610220   .c 61 to 610 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA616908   .c 61 to 643 2 to 584   capped   583/588
(99 %)
1 diff
(99.9 %id)
DB270150 uterus .c 61 to 607 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DT219953 brain .c 62 to 595 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BF128650 B-cells, primary B-cells from tonsils (cell line) .c 63 to 787 1 to 721       721/723
(99 %)
15 diff
(98.0 %id)
CB120069 Liver .c 63 to 544 1 to 482       482/482
(100 %)
0 diff
(100 %id)
CB125387 Liver .c 63 to 523 1 to 461       461/461
(100 %)
0 diff
(100 %id)
DA997129   .c 65 to 524 2 to 461   capped   460/460
(100 %)
2 diff
(99.6 %id)
BP259083 heart .c 67 to 538 1 to 471       471/581
(81 %)
20 diff
(96.6 %id)
CB141118 Liver .c 67 to 669 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
BF688299 eye, normal pigmented retinal epithelium .c 68 to 696 1 to 647       620/648
(95 %)
18 diff
(97.3 %id)
BG324707 Kidney, renal cell adenocarcinoma .c 68 to 753 1 to 683       683/686
(99 %)
7 diff
(99.0 %id)
BM914703 amelanotic melanoma, cell line, skin .c 68 to 761 11 to 702       692/1147
(60 %)
11 diff
(99.1 %id)
BQ218766 epithelioid carcinoma, Pancreas .c 68 to 951 1 to 890 D224N A236C L237P A238G S239E ...     890/890
(100 %)
25 diff
(97.2 %id)
DA923255 small intestine .c 68 to 648 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DN990589 brain, whole brain .c 68 to 691 8 to 631       624/631
(98 %)
6 diff
(99.1 %id)
AA354064   .c 69 to 412 1 to 348       348/358
(97 %)
7 diff
(98.1 %id)
AF087573   .c 69 to 1471 8 to 1410 exact tiling clone, AAA   1403/1410
(99 %)
6 diff
(99.6 %id)
BQ425675 eye, retinoblastoma .c 70 to 886 1 to 819       819/879
(93 %)
5 diff
(99.5 %id)
BM794904 Ascites, stomach .c 70 to 763 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
AF103799   .c 74 to 1075 1 to 1002 exact AAA   1002/1002
(100 %)
5 diff
(99.6 %id)
BF029004 bladder, carcinoma, cell line .c 75 to 539 1 to 470       470/834
(56 %)
12 diff
(98.6 %id)
CN282649 embryonic stem cells, DMSO-treated H9 cellline .c 76 to 737 10 to 671       662/671
(98 %)
6 diff
(99.2 %id)
BU190464 hepatocellular carcinoma, cell line, Liver .c 76 to 882 21 to 837       817/1141
(71 %)
28 diff
(97.6 %id)
CR603712 Placenta Cot 25-normalized .c 77 to 1418 1 to 1342 exact     1342/1342
(100 %)
0 diff
(100 %id)
AL548197 placenta, Placenta Cot 25-normalized .c 77 to 570 1 to 496   fully sequenced,   496/496
(100 %)
5 diff
(99.0 %id)
BI161446 epithelioid carcinoma cell line, Pancreas .c 77 to 920 1 to 864 K93T K123N W124V K125D N126R ...     842/888
(94 %)
45 diff
(95.0 %id)
CN282648 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 78 to 831 1 to 754       754/754
(100 %)
3 diff
(99.7 %id)
BG024778 lymph, lymphoma, cell line .c 79 to 885 1 to 808       808/904
(89 %)
24 diff
(97.4 %id)
BQ650710 hepatocellular carcinoma, cell line, Liver .c 79 to 886 1 to 812       812/849
(95 %)
14 diff
(98.4 %id)
CN282655 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 81 to 777 1 to 697       697/697
(100 %)
0 diff
(100 %id)
BF304704 muscle, rhabdomyosarcoma .c 81 to 831 1 to 742       742/944
(78 %)
32 diff
(96.7 %id)
BF306989 muscle, rhabdomyosarcoma .c 81 to 830 1 to 751       751/839
(89 %)
30 diff
(96.5 %id)
BF307361 muscle, rhabdomyosarcoma .c 81 to 735 1 to 649       649/743
(87 %)
18 diff
(97.6 %id)
BF976368 B-cells, primary B-cells from tonsils (cell line) .c 81 to 933 1 to 866 N126T K201T E218*     866/1088
(79 %)
28 diff
(97.5 %id)
BG282402 melanotic melanoma, skin .c 81 to 867 1 to 805       803/990
(81 %)
26 diff
(97.4 %id)
BG394304 eye, retinoblastoma .c 81 to 790 1 to 705       705/709
(99 %)
9 diff
(98.8 %id)
BG471014 eye, retinoblastoma .c 81 to 838 1 to 760       760/764
(99 %)
15 diff
(98.1 %id)
BG756907 B-cells, primary B-cells from tonsils (cell line) .c 81 to 790 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BG762729 melanotic melanoma, high MDR (cell line), skin .c 81 to 760 1 to 680       680/680
(100 %)
0 diff
(100 %id)
BQ232740 melanotic melanoma, skin .c 81 to 729 11 to 661       651/874
(74 %)
11 diff
(98.8 %id)
BF795694 lymph, lymphoma, cell line .c 83 to 815 1 to 725       725/733
(98 %)
13 diff
(98.3 %id)
BQ233034 melanotic melanoma, skin .c 83 to 853 1 to 780       780/884
(88 %)
21 diff
(97.7 %id)
BF182924 large cell carcinoma, lung .c 84 to 810 1 to 727       727/903
(80 %)
17 diff
(98.2 %id)
CN282656 embryonic stem cells, DMSO-treated H9 cellline .c 85 to 420 8 to 343       336/343
(97 %)
6 diff
(98.3 %id)
BU942611 mixed (pool of 40 RNAs) .c 86 to 728 1 to 644       644/815
(79 %)
7 diff
(99.2 %id)
CN282646 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 87 to 781 1 to 695       695/695
(100 %)
0 diff
(100 %id)
BE794305 lung, small cell carcinoma .c 87 to 857 1 to 770       770/770
(100 %)
8 diff
(99.0 %id)
BM927760 hepatocellular carcinoma, cell line, Liver .c 88 to 870 1 to 788       788/1037
(75 %)
5 diff
(99.6 %id)
BQ064337 lymph, lymphoma, cell line .c 88 to 886 1 to 802       802/1016
(78 %)
7 diff
(99.4 %id)
CN282654 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 89 to 665 1 to 577       577/577
(100 %)
5 diff
(99.2 %id)
CN282659 embryonic stem cells, DMSO-treated H9 cellline .c 90 to 696 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BM849551 myeloma .c 90 to 682 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BM785217 myeloma .c 90 to 740 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BM848498 myeloma .c 90 to 455 1 to 366       366/366
(100 %)
0 diff
(100 %id)
BM563765 astrocytoma grade IV, cell line, brain .c 92 to 831 1 to 743       743/935
(79 %)
18 diff
(98.1 %id)
TI_149308718   .c 95 to 1095 1086 to 89 V3* AAA   998/1010
(98 %)
27 diff
(97.4 %id)
BE273001 Kidney, renal cell adenocarcinoma .c 99 to 787 1 to 685       685/688
(99 %)
14 diff
(98.0 %id)
BE382653 brain, neuroblastoma .c 100 to 720 1 to 621       621/623
(99 %)
1 diff
(99.9 %id)
BE252047 eye, retinoblastoma .c 101 to 729 1 to 633       633/756
(83 %)
12 diff
(98.5 %id)
BE251272 eye, retinoblastoma .c 101 to 736 1 to 633       633/633
(100 %)
9 diff
(98.6 %id)
BG774201 choriocarcinoma, placenta .c 101 to 930 1 to 838       838/842
(99 %)
20 diff
(97.7 %id)
BI161028 epithelioid carcinoma cell line, Pancreas .c 101 to 699 1 to 608       572/733
(78 %)
26 diff
(96.5 %id)
BI192701 epithelioid carcinoma cell line, Pancreas .c 101 to 538 1 to 448       448/998
(44 %)
13 diff
(98.7 %id)
BE250704 muscle, rhabdomyosarcoma .c 102 to 863 1 to 761       761/762
(99 %)
2 diff
(99.8 %id)
BE019456 muscle, rhabdomyosarcoma .c 102 to 724 1 to 623       623/624
(99 %)
3 diff
(99.6 %id)
BE540526 cervix .c 102 to 837 1 to 736       736/913
(80 %)
33 diff
(96.4 %id)
BE780334 eye, retinoblastoma .c 102 to 729 1 to 617       615/714
(86 %)
39 diff
(94.6 %id)
CN282653 embryonic stem cells, DMSO-treated H9 cellline .c 105 to 882 1 to 778       778/778
(100 %)
3 diff
(99.7 %id)
BU195763 leiomyosarcoma, uterus .c 107 to 886 1 to 785       785/903
(86 %)
13 diff
(98.6 %id)
BF032984 adenocarcinoma, ovary .c 131 to 847 1 to 716       716/717
(99 %)
15 diff
(98.0 %id)
BF971907 leiomyosarcoma cell line, uterus .c 169 to 985 1 to 834       834/1116
(74 %)
33 diff
(97.1 %id)
BU959501 mixed (pool of 40 RNAs) .c 220 to 886 1 to 673       673/800
(84 %)
12 diff
(98.5 %id)
TI_149313165   .c 234 to 1067 909 to 89   AAA   821/948
(86 %)
16 diff
(98.4 %id)
TI_154110630   .c 234 to 1067 901 to 68   AAA   834/966
(86 %)
10 diff
(99.0 %id)
BU508744 leiomyosarcoma, uterus .c 235 to 1030 835 to 33   AAA Submitted on the opposite strand 803/906
(88 %)
25 diff
(97.3 %id)
AI718349 colon .c 255 to 1034 779 to 1       779/779
(100 %)
13 diff
(98.4 %id)
AI668918 Prostate .c 273 to 1023 754 to 8       747/754
(99 %)
10 diff
(98.7 %id)
BU687182 lung .c 354 to 1095 760 to 19   AAA   742/742
(100 %)
0 diff
(100 %id)
BQ182982 Chondrosarcoma, Left Pubic Bone .c 361 to 1067 720 to 15   AAA   706/706
(100 %)
1 diff
(99.9 %id)
CF541207 lung .c 364 to 1067 717 to 15   AAA   703/703
(100 %)
1 diff
(99.9 %id)
AA378167 synovial membrane .c 371 to 545 1 to 175       175/175
(100 %)
0 diff
(100 %id)
CB528316 Aveolar Macrophage, lung .c 373 to 1092 738 to 19   AAA   720/720
(100 %)
1 diff
(99.9 %id)
CF140613 CNCAP(3)T-225 cell line, Prostate .c 418 to 878 8 to 468       461/468
(98 %)
6 diff
(98.8 %id)
AA830891 germinal center B cell .c 431 to 815 1 to 385     Submitted on the opposite strand 385/385
(100 %)
0 diff
(100 %id)
AI819677 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 447 to 1031 585 to 1       585/585
(100 %)
6 diff
(99.0 %id)
AI801052 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 450 to 1030 598 to 18   AAA   581/581
(100 %)
4 diff
(99.4 %id)
AI910487 colon, colon tumor, RER+ .c 450 to 1031 606 to 18   AAA   589/589
(100 %)
17 diff
(97.2 %id)
AL572842 placenta, Placenta Cot 25-normalized .c 538 to 1418 882 to 1   fully sequenced,   882/882
(100 %)
3 diff
(99.7 %id)
BE707331 head_neck .c 547 to 1032 1 to 486       486/486
(100 %)
2 diff
(99.6 %id)
N56383   .c 580 to 800 1 to 221       221/221
(100 %)
5 diff
(97.8 %id)
BG389547 embryonal carcinoma, cell line, testis .c 589 to 1030 1 to 444   AAA   442/444
(99 %)
9 diff
(98.0 %id)
TI_149297556   .c 614 to 1471 928 to 77   AAA   852/974
(87 %)
15 diff
(98.5 %id)
AW088614 ovary, tumor, 5 pooled (see description) .c 651 to 1478 821 to 1       823/821
(100 %)
28 diff
(96.6 %id)
BU533529 mixed (pool of 40 RNAs) .c 696 to 1031 1 to 336   AAA   336/336
(100 %)
2 diff
(99.5 %id)
AL527272 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 699 to 1439 740 to 1   fully sequenced,   740/740
(100 %)
20 diff
(97.3 %id)
BU536145 mixed (pool of 40 RNAs) .c 700 to 1068 1 to 369   AAA   369/369
(100 %)
3 diff
(99.2 %id)
BU190455 melanotic melanoma, cell line, skin .c 732 to 1566 1 to 844       844/848
(99 %)
11 diff
(98.8 %id)
BE277909 melanotic melanoma, skin .c 734 to 1419 23 to 707       685/708
(96 %)
8 diff
(98.9 %id)
BG744994 blood, natural killer cells, cell line .c 741 to 1604 870 to 1       870/994
(87 %)
7 diff
(99.3 %id)
CB528891 Aveolar Macrophage, lung .c 751 to 1469 735 to 17   AAA   719/719
(100 %)
1 diff
(99.9 %id)
CB529893 Aveolar Macrophage, lung .c 751 to 1471 740 to 19   AAA   722/722
(100 %)
1 diff
(99.9 %id)
BE728454 melanotic melanoma, skin .c 753 to 1499 1 to 733       733/857
(85 %)
31 diff
(96.4 %id)
BE729931 melanotic melanoma, skin .c 753 to 1468 1 to 714       714/714
(100 %)
16 diff
(97.8 %id)
BM982597 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 755 to 1471 736 to 19   AAA   718/718
(100 %)
1 diff
(99.9 %id)
CA443187 lung, Metastatic Chondrosarcoma .c 772 to 1478 723 to 19   AAA   705/713
(98 %)
2 diff
(99.8 %id)
CA443323 lung, Metastatic Chondrosarcoma .c 774 to 1478 724 to 19   AAA   706/712
(99 %)
1 diff
(99.9 %id)
AA577245 colon, colon tumor RER+ .c 813 to 1034 222 to 1       222/222
(100 %)
1 diff
(99.6 %id)
BG255202 adenocarcinoma, cell line, Prostate .c 843 to 1604 1 to 750       750/976
(76 %)
17 diff
(98.3 %id)
BU608855 Human Lung Epithelial cells, lung .c 888 to 1476 606 to 19   AAA   588/588
(100 %)
6 diff
(99.0 %id)
AA522893 lung, lung tumor .c 902 to 1472 579 to 10       570/579
(98 %)
0 diff
(100 %id)
BG939862 bone marrow stroma .c 930 to 1471 595 to 54   AAA   542/542
(100 %)
8 diff
(98.6 %id)
AW589785 pooled germ cell tumors .c 930 to 1479 550 to 1       550/550
(100 %)
0 diff
(100 %id)
BF983252 duodenal adenocarcinoma, cell line, small intestine .c 962 to 1708 12 to 747       736/749
(98 %)
21 diff
(97.2 %id)
AI458744 carcinoid, lung .c 982 to 1429 1 to 448     Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
BF939128 carcinoid, lung .c 984 to 1428 1 to 446     Submitted on the opposite strand 446/446
(100 %)
4 diff
(99.2 %id)
BF589982 Kidney .c 1022 to 1471 453 to 4       450/462
(97 %)
0 diff
(100 %id)
CB240566 Human Lung Epithelial cells, lung .c 1022 to 1467 459 to 19   AAA   441/450
(98 %)
7 diff
(98.5 %id)
BF000469 colon, colon tumor, RER+ .c 1026 to 1477 452 to 1       452/452
(100 %)
3 diff
(99.4 %id)
AW594137 pooled germ cell tumors .c 1033 to 1480 448 to 1       448/451
(99 %)
2 diff
(99.6 %id)
BE677896 pooled .c 1033 to 1470 446 to 9       438/446
(98 %)
0 diff
(100 %id)
DB169704 kidney, tumor tissue .c 1038 to 1541 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
FN100265 breast carcinoma .c 1044 to 1126 1 to 83       83/83
(100 %)
3 diff
(96.4 %id)
CB108265 Liver .c 1057 to 1478 1 to 423       423/427
(99 %)
2 diff
(99.6 %id)
BM792753 stomach .c 1067 to 1471 1 to 404       404/418
(96 %)
2 diff
(99.6 %id)
BM836180 stomach .c 1067 to 1464 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
BE299454 muscle, rhabdomyosarcoma .c 1075 to 1848 775 to 3   tiling clone,   773/776
(99 %)
0 diff
(100 %id)
AW962782   .c 1101 to 1462 363 to 1     Submitted on the opposite strand 363/363
(100 %)
16 diff
(95.6 %id)
AW196606 pooled germ cell tumors .c 1107 to 1471 372 to 8       365/372
(98 %)
0 diff
(100 %id)
AI655231 pooled germ cell tumors .c 1110 to 1469 360 to 1       360/360
(100 %)
0 diff
(100 %id)
BE206046 muscle, rhabdomyosarcoma .c 1141 to 1630 488 to 1       488/488
(100 %)
13 diff
(97.4 %id)
C02117   .c 1260 to 1366 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AA370709 Prostate .c 1263 to 1461 199 to 1     Submitted on the opposite strand 199/199
(100 %)
0 diff
(100 %id)
N36013 melanocyte .c 1336 to 1777 448 to 1       448/479
(93 %)
23 diff
(95.2 %id)
BE207821 muscle, rhabdomyosarcoma .c 1468 to 1901 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
AA075754   .c 1492 to 1965 1 to 474       474/475
(99 %)
16 diff
(96.7 %id)
BG171805 hypernephroma, cell line, Kidney .c 1501 to 1899 1 to 402   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 402/402
(100 %)
9 diff
(97.8 %id)
BQ424029 melanotic melanoma, skin .c 1658 to 2493 53 to 895       843/896
(94 %)
20 diff
(97.8 %id)
BE018774 cervix .c 1660 to 2200 1 to 541       541/541
(100 %)
6 diff
(98.9 %id)
BU956486 adenocarcinoma, cell line, breast .c 1745 to 2616 1 to 878   tiling clone,   878/882
(99 %)
8 diff
(99.1 %id)
BG031984 breast, mammary adenocarcinoma, cell line .c 2068 to 2745 19 to 693       675/935
(72 %)
12 diff
(98.8 %id)
AW580625 leiomios .c 2070 to 2511 444 to 2       443/447
(99 %)
0 diff
(100 %id)
BE383228 brain, neuroblastoma .c 2209 to 2842 1 to 634       634/634
(100 %)
6 diff
(99.1 %id)
AA837509 epithelium (cell line), Prostate .c 2232 to 2986 755 to 1       755/756
(99 %)
55 diff
(92.8 %id)
DW407679 Liver .c 2233 to 2712 16 to 495       480/495
(96 %)
6 diff
(98.8 %id)
BG392751 embryonal carcinoma, cell line, testis .c 2233 to 3023 1 to 798       798/984
(81 %)
19 diff
(98.1 %id)
AI949707 Kidney .c 2235 to 2710 477 to 2       476/478
(99 %)
0 diff
(100 %id)
BU620441 cell lines, Chondrosarcoma .c 2235 to 2711 496 to 19   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
AA101403 brain, neuroepithelial cells .c 2237 to 2537 308 to 1     Submitted on the opposite strand 308/369
(83 %)
7 diff
(98.2 %id)
AI657022 pooled germ cell tumors .c 2244 to 2693 450 to 1       450/451
(99 %)
1 diff
(99.8 %id)
AA582227 Kidney, kidney tumor .c 2252 to 2657 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AW081672 colon, moderately differentiated adenocarcinoma .c 2255 to 2348 94 to 1       94/94
(100 %)
0 diff
(100 %id)
BM971715 lung .c 2261 to 2855 611 to 17   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 595/595
(100 %)
2 diff
(99.7 %id)
AA487662 lung .c 2271 to 2672 1 to 399   fully sequenced,   399/399
(100 %)
2 diff
(99.5 %id)
AW513499 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2274 to 2852 583 to 5       579/590
(98 %)
0 diff
(100 %id)
TI_59385968   .c 2283 to 2831 61 to 609       549/551
(99 %)
5 diff
(99.1 %id)
BM006015 hepatocellular carcinoma, cell line, Liver .c 2284 to 2831 1 to 548       548/550
(99 %)
5 diff
(99.1 %id)
BQ064502 lymph, lymphoma, cell line .c 2286 to 3012 1 to 727   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 727/727
(100 %)
9 diff
(98.8 %id)
BE696388 colon .c 2290 to 2602 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
AI620663 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2294 to 2848 552 to 1       552/555
(99 %)
30 diff
(94.6 %id)
AA599847 bone marrow stroma .c 2295 to 2711 417 to 1       417/417
(100 %)
0 diff
(100 %id)
BE250723 muscle, rhabdomyosarcoma .c 2301 to 2973 711 to 39       673/1072
(62 %)
0 diff
(100 %id)
BE088606 breast .c 2305 to 2513 230 to 20     Submitted on the opposite strand 211/240
(87 %)
0 diff
(100 %id)
BF941691 Prostate .c 2321 to 2711 392 to 1       392/394
(99 %)
9 diff
(97.8 %id)
BE315367 adenocarcinoma cell line, ovary .c 2328 to 3012 1 to 682   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 682/682
(100 %)
9 diff
(98.7 %id)
AW173575 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2366 to 2863 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
BQ368365 placenta_normal .c 2372 to 2576 216 to 9       208/223
(93 %)
3 diff
(98.7 %id)
CA310202 Alveolar Macrophage, lung .c 2382 to 3094 729 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 711/711
(100 %)
4 diff
(99.5 %id)
AW897715 nervous_normal .c 2394 to 2567 1 to 175       175/186
(94 %)
3 diff
(98.4 %id)
BX117311 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2412 to 2852 450 to 10     Submitted on the opposite strand 441/450
(98 %)
0 diff
(100 %id)
BU161766 melanotic melanoma, skin .c 2413 to 3242 5 to 847       843/851
(99 %)
6 diff
(99.3 %id)
BE163416 head_neck .c 2427 to 2626 201 to 1     Submitted on the opposite strand 201/201
(100 %)
3 diff
(98.6 %id)
AI049623   .c 2431 to 2848 418 to 1       418/418
(100 %)
3 diff
(99.3 %id)
T89426 liver and spleen .c 2437 to 2713 278 to 1       278/280
(99 %)
4 diff
(98.6 %id)
BF512492   .c 2442 to 2711 287 to 18   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 270/270
(100 %)
7 diff
(97.5 %id)
BQ309334 breast .c 2447 to 2632 14 to 194       181/194
(93 %)
6 diff
(97.0 %id)
BQ309395 breast .c 2447 to 2632 14 to 194       181/194
(93 %)
6 diff
(97.0 %id)
AI696252 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2450 to 2717 269 to 1       269/269
(100 %)
1 diff
(99.7 %id)
BU565234 mixed (pool of 40 RNAs) .c 2453 to 2718 1 to 266       266/352
(75 %)
2 diff
(99.5 %id)
AW062935 stomach .c 2454 to 2659 1 to 205       205/205
(100 %)
5 diff
(97.6 %id)
AI424558 Prostate .c 2454 to 2711 262 to 1       262/262
(100 %)
3 diff
(98.9 %id)
AI620675 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 2456 to 2848 393 to 1       393/393
(100 %)
4 diff
(99.0 %id)
AW387138 stomach .c 2457 to 2673 230 to 11       220/230
(95 %)
11 diff
(95.3 %id)
W56054 lung .c 2459 to 2880 1 to 421       421/425
(99 %)
12 diff
(97.2 %id)
AW178943 stomach .c 2468 to 2659 11 to 203       193/203
(95 %)
6 diff
(97.1 %id)
BQ214663 melanotic melanoma, skin .c 2471 to 3018 1 to 552       552/1032
(53 %)
18 diff
(98.3 %id)
DB355036 whole embryo, mainly head .c 2486 to 3012 528 to 1       528/530
(99 %)
14 diff
(97.4 %id)
AU145314 whole embryo, mainly head .c 2528 to 3094 562 to 1       562/571
(98 %)
15 diff
(97.4 %id)
AW513505 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2537 to 2852 320 to 5       316/320
(98 %)
0 diff
(100 %id)
BE302337 cervix .c 2552 to 3014 463 to 1       463/463
(100 %)
7 diff
(98.5 %id)
CA437921 lung, Metastatic Chondrosarcoma .c 2609 to 3030 422 to 1   tiling clone,   422/430
(98 %)
3 diff
(99.4 %id)
AA758771   .c 2614 to 2687 95 to 22   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 74/74
(100 %)
0 diff
(100 %id)
CN414212 embryonic stem cells, DMSO-treated H9 cellline .c 2615 to 3336 1 to 722   tiling clone,   722/722
(100 %)
11 diff
(98.5 %id)
BF929135 nervous_tumor .c 2638 to 2744 107 to 1     Submitted on the opposite strand 107/128
(83 %)
0 diff
(100 %id)
AA487452 lung .c 2642 to 2996 354 to 1   fully sequenced,   354/354
(100 %)
16 diff
(95.5 %id)
DB360987 mammary gland .c 2835 to 3391 557 to 1   tiling clone,   557/557
(100 %)
26 diff
(95.4 %id)
AU098686   .d 1 to 299 2 to 300   tiling clone,   300/300
(100 %)
4 diff
(98.7 %id)
BP221605 colon .d 1 to 564 2 to 565 S3F Q5H tiling clone,   565/565
(100 %)
4 diff
(99.3 %id)
BE311892 Kidney, renal cell adenocarcinoma .e 1 to 687 15 to 698 K133R K134T Q151R Q152R T153R ... tiling clone,   689/751
(91 %)
18 diff
(97.7 %id)
BQ887758 eye, retinoblastoma .f 1 to 884 1 to 890 exact tiling clone,   890/892
(99 %)
13 diff
(98.6 %id)
BE299794 muscle, rhabdomyosarcoma .g 1 to 715 1 to 714 exact tiling clone, fully sequenced,   714/714
(100 %)
1 diff
(99.9 %id)
BE394427 endometrium, adenocarcinoma cell line, uterus .g 1 to 485 1 to 485       485/487
(99 %)
1 diff
(99.8 %id)
BE299497 muscle, rhabdomyosarcoma .g 654 to 1403 757 to 5   tiling clone, fully sequenced,   753/757
(99 %)
3 diff
(99.7 %id)
BG575843 breast, mammary adenocarcinoma, cell line .h 1 to 810 1 to 814 A36P S37P C38A L39S E40K ... tiling clone,   814/949
(85 %)
16 diff
(98.4 %id)
BG419751 Kidney, renal cell adenocarcinoma .h 4 to 777 1 to 767 R129G Q130S L131* tiling clone,   767/917
(83 %)
42 diff
(95.5 %id)
AV710647 adrenal cortico adenoma for Cushing'ssyndrome .h 16 to 798 1 to 779 exact tiling clone,   779/780
(99 %)
11 diff
(98.6 %id)
CA415526 Chondrosarcoma Grade II, Left Pelvis .i 1 to 666 683 to 19 A6X F18X L57X tiling clone, AAA   665/668
(99 %)
1 diff
(99.9 %id)
AL525648 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .j 1 to 308 6 to 318   tiling clone, to resequence,   318/356
(89 %)
9 diff
(97.5 %id)
CN282650 embryonic stem cells, cell lines H1, H7, andH9 .j 47 to 560 1 to 514   tiling clone,   514/514
(100 %)
3 diff
(99.5 %id)
AW904802 nervous_normal .j 255 to 484 233 to 4       230/236
(97 %)
0 diff
(100 %id)
AL525597 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .j 1570 to 1857 292 to 1   tiling clone, to resequence,   621/826
(75 %)
32 diff
(96.2 %id)
TI_159696504   .k-u 1 to 889 55 to 932     Submitted on the opposite strand 878/1091
(80 %)
28 diff
(97.5 %id)
CN336778 embryonic stem cells, cell lines H1, H7, andH9 .k-u 5 to 366 1 to 362   tiling clone,   362/362
(100 %)
1 diff
(99.8 %id)
CN480523 Cell Line, Chondrosarcoma .k-u 5 to 745 1 to 740     Submitted on the opposite strand 740/740
(100 %)
13 diff
(98.3 %id)
R70602 placenta .k-u 93 to 418 1 to 329       329/332
(99 %)
10 diff
(97.0 %id)
R74304 placenta .k-u 93 to 485 1 to 395       395/397
(99 %)
10 diff
(97.5 %id)
CN336779 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k-u 217 to 717 1 to 500       500/500
(100 %)
2 diff
(99.6 %id)
TI_159681415   .k-u 229 to 950 803 to 82   tiling clone,   722/1118
(64 %)
0 diff
(100 %id)
BE294382 muscle, rhabdomyosarcoma .k-u 284 to 932 1 to 647       647/686
(94 %)
42 diff
(93.9 %id)
BF807456 colon_ins .k-u 298 to 601 318 to 12     Submitted on the opposite strand 307/319
(96 %)
0 diff
(100 %id)
BE172799 head_neck .k-u 384 to 574 6 to 196       191/196
(97 %)
6 diff
(97.0 %id)
BE172968 head_neck .k-u 386 to 574 25 to 213       189/213
(88 %)
5 diff
(97.7 %id)
BM910684 astrocytoma grade IV, cell line, brain .k-u 401 to 1082 23 to 707   tiling clone,   685/1117
(61 %)
17 diff
(98.5 %id)
AI435826 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 453 to 949 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AA179158   .k-u 492 to 833 341 to 1       341/341
(100 %)
2 diff
(99.5 %id)
AK022602   .k-u 539 to 2784 1 to 2248   tiling clone, available from FLJ,   2248/2248
(100 %)
8 diff
(99.7 %id)
AU124706   .k-u 540 to 1234 2 to 696   capped   695/698
(99 %)
4 diff
(99.5 %id)
AJ707071 heart .k-u 546 to 949 16 to 418       403/418
(96 %)
6 diff
(98.6 %id)
BU625522 cell lines, Enchondroma .k-u 614 to 1231 636 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 618/627
(98 %)
2 diff
(99.7 %id)
AW376069 colon .k-u 651 to 913 1 to 261       261/261
(100 %)
3 diff
(98.9 %id)
AU125854   .k-u 670 to 1342 2 to 674   capped   673/673
(100 %)
2 diff
(99.8 %id)
TI_154166829   .k-u 675 to 1216 621 to 80     Submitted on the opposite strand 542/543
(99 %)
2 diff
(99.7 %id)
AA948207 pooled germ cell tumors .k-u 683 to 1186 504 to 2       503/504
(99 %)
0 diff
(100 %id)
BE885208 leiomyosarcoma, uterus .k-u 704 to 1301 1 to 599       599/599
(100 %)
10 diff
(98.4 %id)
BE537973 cervix .k-u 712 to 1482 1 to 764       764/818
(93 %)
22 diff
(97.4 %id)
BM839301 Ascites, stomach .k-u 751 to 1247 499 to 4     Submitted on the opposite strand 496/499
(99 %)
0 diff
(100 %id)
CF137398 lymph .k-u 815 to 1216 409 to 8     Submitted on the opposite strand 402/409
(98 %)
0 diff
(100 %id)
BE536980 cervix .k-u 867 to 1480 1 to 609       609/609
(100 %)
8 diff
(98.7 %id)
AW404457 lymph .k-u 970 to 1267 1 to 298   tiling clone,   298/298
(100 %)
3 diff
(99.0 %id)
BQ775194 Bone, Human Chondrosarcoma Cell Line .k-u 1011 to 1548 556 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 538/574
(93 %)
19 diff
(96.7 %id)
BM997279 lung, Metastatic Chondrosarcoma .k-u 1027 to 1548 540 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 522/522
(100 %)
1 diff
(99.9 %id)
AA669842 bone marrow stroma .k-u 1077 to 1412 336 to 1       336/336
(100 %)
4 diff
(98.9 %id)
BQ345847 nervous_tumor .k-u 1078 to 1423 1 to 345       345/376
(91 %)
15 diff
(96.1 %id)
F24556 pectoral muscle (after mastectomy) .k-u 1171 to 1483 1 to 313       313/313
(100 %)
4 diff
(98.8 %id)
AA649505 alveolar rhabdomyosarcoma .k-u 1178 to 1561 383 to 1       383/383
(100 %)
4 diff
(99.0 %id)
DB125919 thymus .k-u 1401 to 1959 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
N78461 multiple sclerosis lesions .k-u 1512 to 1762 12 to 263       252/263
(95 %)
6 diff
(97.8 %id)
CN393723 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k-u 1560 to 1888 1 to 331       331/331
(100 %)
3 diff
(99.1 %id)
BM801950 eye, retinoblastoma .k-u 1587 to 2454 7 to 873   tiling clone,   867/889
(97 %)
10 diff
(98.9 %id)
CN393722 embryonic stem cells, cell lines H1, H7, andH9 .k-u 1631 to 2295 1 to 663       663/663
(100 %)
3 diff
(99.6 %id)
CN393725 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k-u 1663 to 2060 1 to 398       398/398
(100 %)
0 diff
(100 %id)
DA600601   .k-u 1692 to 2252 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
BI088073 cervix .k-u 1721 to 2393 1 to 672       672/675
(99 %)
9 diff
(98.7 %id)
BE746723 adenocarcinoma cell line, ovary .k-u 1770 to 2580 1 to 808       808/872
(92 %)
22 diff
(97.5 %id)
BF836881 head_neck .k-u 1840 to 2148 308 to 1     Submitted on the opposite strand 308/308
(100 %)
3 diff
(99.1 %id)
CN393724 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k-u 1857 to 2353 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
BU521297 leiomyosarcoma, uterus .k-u 1956 to 2454 1 to 499       499/789
(63 %)
8 diff
(99.0 %id)
DA948992 Spleen .k-u 2061 to 2452 2 to 391   capped   390/390
(100 %)
2 diff
(99.5 %id)
AU148511   .k-u 2261 to 2784 522 to 1       522/522
(100 %)
12 diff
(97.8 %id)
DB363426   .k-u 2269 to 2784 517 to 1   tiling clone,   517/522
(99 %)
14 diff
(97.4 %id)
BF840205 head_neck .k-u 2305 to 2719 418 to 4     Submitted on the opposite strand 415/418
(99 %)
0 diff
(100 %id)
EH351892   .k-u 2331 to 2408 1 to 78       78/78
(100 %)
0 diff
(100 %id)
F07579 brain, total brain .k-u 2366 to 2695 1 to 330       330/330
(100 %)
2 diff
(99.4 %id)
BU161945 eye, retinoblastoma .k-u 2579 to 3464 1 to 889 I13F S14N K22* tiling clone,   889/923
(96 %)
25 diff
(97.3 %id)
CN270030 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k-u 2660 to 3258 1 to 599       599/599
(100 %)
4 diff
(99.4 %id)
BF725881 eye, Iris .k-u 2673 to 3159 1 to 487       487/487
(100 %)
4 diff
(99.2 %id)
Z35729   .k-u 2714 to 3064 1 to 351       351/351
(100 %)
6 diff
(98.3 %id)
BU171110 eye, retinoblastoma .k-u 2744 to 3431 733 to 43   AAA Submitted on the opposite strand 691/871
(79 %)
22 diff
(97.5 %id)
BQ225310 leiomyosarcoma, uterus .k-u 2751 to 3570 1 to 820 exact AAA   820/820
(100 %)
8 diff
(99.1 %id)
TI_149315983   .k-u 2783 to 3572 883 to 95 exact AAA   789/985
(80 %)
10 diff
(99.0 %id)
BU954468 mixed (pool of 40 RNAs) .k-u 2829 to 3564 1 to 738 K50X E53R N55L AAA   738/741
(99 %)
18 diff
(97.6 %id)
BU624446 cell lines, Enchondroma .k-u 2871 to 3572 720 to 19 exact AAA   702/702
(100 %)
1 diff
(99.9 %id)
BQ020764 lung, Metastatic Chondrosarcoma .k-u 2889 to 3564 694 to 19 exact AAA   676/676
(100 %)
0 diff
(100 %id)
BQ001643 lung, Metastatic Chondrosarcoma .k-u 2896 to 3564 687 to 19 exact AAA   669/669
(100 %)
1 diff
(99.9 %id)
BQ775928 Bone, Human Chondrosarcoma Cell Line .k-u 2911 to 3564 672 to 19 exact AAA   654/654
(100 %)
0 diff
(100 %id)
CB321820 lung, Primary Lung Cystic Fibrosis EpithelialCells .k-u 2913 to 3572 677 to 19 exact AAA   659/659
(100 %)
3 diff
(99.6 %id)
BQ269503 Pancreas, Purified pancreatic islet .k-u 2917 to 3553 1 to 637 exact     637/637
(100 %)
2 diff
(99.7 %id)
CA941565 Pancreas, Purified pancreatic islet .k-u 2927 to 3270 1 to 344   fully sequenced,   344/344
(100 %)
0 diff
(100 %id)
CD518919 White Matter .k-u 2933 to 3482 6 to 557 exact     552/1086
(50 %)
6 diff
(99.5 %id)
CD556980 brain, Pituitary .k-u 2937 to 3424 96 to 588       493/1427
(34 %)
19 diff
(98.7 %id)
AA090904   .k-u 2951 to 3174 1 to 223       223/226
(98 %)
7 diff
(97.0 %id)
N88442   .k-u 2951 to 3235 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
BM989356 Fibrosarcoma .k-u 2955 to 3572 636 to 19 exact AAA   618/618
(100 %)
0 diff
(100 %id)
CK825762 Pancreas, Purified pancreatic islet .k-u 2968 to 3544 1 to 577 exact   Submitted on the opposite strand 577/577
(100 %)
0 diff
(100 %id)
BM929874 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k-u 2986 to 3478 1 to 493 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 493/493
(100 %)
0 diff
(100 %id)
AA887054 pooled germ cell tumors .k-u 3003 to 3572 584 to 17 S36T Y37T A38L N39I Y40T ... AAA   568/568
(100 %)
3 diff
(99.5 %id)
BQ772903 Chondrosarcoma Cell line .k-u 3011 to 3580 588 to 19 exact AAA   570/570
(100 %)
3 diff
(99.5 %id)
BF038479 adenocarcinoma, ovary .k-u 3017 to 3580 1 to 564 exact AAA   564/564
(100 %)
0 diff
(100 %id)
BF064224 pooled .k-u 3042 to 3565 529 to 6 exact     524/529
(99 %)
0 diff
(100 %id)
BQ286141 Pancreas, Purified pancreatic islet .k-u 3044 to 3563 520 to 1 exact     520/520
(100 %)
0 diff
(100 %id)
BE149756 head_neck .k-u 3050 to 3514 492 to 29 exact   Submitted on the opposite strand 464/499
(92 %)
0 diff
(100 %id)
EL947840 eyeball .k-u 3059 to 3580 551 to 29 exact AAA Submitted on the opposite strand 523/523
(100 %)
2 diff
(99.7 %id)
AI888772 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k-u 3060 to 3582 530 to 7 F45L N46*     524/530
(98 %)
0 diff
(100 %id)
BE834200 ovary .k-u 3077 to 3327 1 to 251       251/251
(100 %)
8 diff
(96.9 %id)
BF196776 brain, glioblastoma (pooled) .k-u 3079 to 3564 486 to 1 exact     486/486
(100 %)
0 diff
(100 %id)
AI361025 brain, glioblastoma (pooled) .k-u 3094 to 3572 479 to 1 exact     479/479
(100 %)
0 diff
(100 %id)
AI554353 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .k-u 3094 to 3582 489 to 1 exact     489/489
(100 %)
1 diff
(99.8 %id)
BF055467 pooled .k-u 3094 to 3564 484 to 14 exact AAA   471/471
(100 %)
1 diff
(99.8 %id)
AI563958 anaplastic oligodendroglioma, brain .k-u 3100 to 3564 465 to 1 exact     465/465
(100 %)
1 diff
(99.8 %id)
BE675499 B-cell, chronic lymphotic leukemia .k-u 3128 to 3582 458 to 4 exact     455/458
(99 %)
0 diff
(100 %id)
AI333669 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 3139 to 3582 445 to 4 exact     442/445
(99 %)
0 diff
(100 %id)
AI376617 pooled .k-u 3143 to 3582 440 to 1 exact tiling clone,   440/440
(100 %)
0 diff
(100 %id)
N62736 multiple sclerosis lesions .k-u 3145 to 3564 423 to 1 R35Q S36E     423/428
(98 %)
11 diff
(97.5 %id)
AI336520 adenocarcinoma, colon .k-u 3145 to 3582 441 to 4 exact     438/441
(99 %)
0 diff
(100 %id)
AI080353 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 3148 to 3572 422 to 1 S36T Y37T A38L N39I Y40T ...     422/422
(100 %)
3 diff
(99.3 %id)
AW382296 head_neck .k-u 3160 to 3467 310 to 4 N39K     307/310
(99 %)
0 diff
(100 %id)
AW371204 breast .k-u 3162 to 3442 293 to 13       281/293
(95 %)
0 diff
(100 %id)
BX282902 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k-u 3172 to 3580 423 to 15 Y40X L42X N55T AAA   409/409
(100 %)
8 diff
(98.1 %id)
CR738131 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k-u 3172 to 3580 423 to 15 Y40X L42X N55T AAA   409/409
(100 %)
8 diff
(98.1 %id)
BF109168 pooled .k-u 3178 to 3565 395 to 8 exact     388/395
(98 %)
0 diff
(100 %id)
BE645037 pooled .k-u 3181 to 3565 385 to 1 exact     385/385
(100 %)
0 diff
(100 %id)
AA282992 ovarian tumor, ovary .k-u 3187 to 3564 377 to 1 S36T     377/377
(100 %)
3 diff
(99.3 %id)
BM782064 myeloma .k-u 3204 to 3581 1 to 378 exact     378/392
(96 %)
1 diff
(99.8 %id)
BM684309 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k-u 3217 to 3478 277 to 16 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 262/262
(100 %)
0 diff
(100 %id)
AI092038 heart .k-u 3235 to 3500 264 to 1 S36T Y40*     264/264
(100 %)
3 diff
(98.9 %id)
CA337324 posterior rhombomeres 5-8 (4 pooled) .k-u 3235 to 3579 1 to 345 exact AAA   345/345
(100 %)
0 diff
(100 %id)
T17425   .k-u 3235 to 3580 345 to 1 K3X N24X S36T Y37T A38L ...     345/345
(100 %)
2 diff
(99.5 %id)
AA401186 ovarian tumor, ovary .k-u 3238 to 3565 328 to 1 R35T S36E     328/328
(100 %)
2 diff
(99.4 %id)
CA941273 Pancreas, Purified pancreatic islet .k-u 3240 to 3563 324 to 1 exact fully sequenced,   324/324
(100 %)
0 diff
(100 %id)
BE857446 brain, glioblastoma (pooled) .k-u 3241 to 3580 340 to 1 exact     340/340
(100 %)
0 diff
(100 %id)
BG108084 Bone, osteosarcoma, cell line .k-u 3244 to 3580 12 to 348 exact AAA   337/348
(96 %)
10 diff
(97.2 %id)
AI371232 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k-u 3249 to 3563 346 to 32 exact AAA   315/315
(100 %)
0 diff
(100 %id)
AI538047 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k-u 3266 to 3565 307 to 8 S14A     300/307
(97 %)
0 diff
(100 %id)
BI496094 cochlea, ear .k-u 3289 to 3564 1 to 276   fully sequenced, AAA   276/276
(100 %)
4 diff
(98.6 %id)
AI244437 Kidney .k-u 3313 to 3572 261 to 1       261/261
(100 %)
8 diff
(97.0 %id)
BI496093 cochlea, ear .k-u 3334 to 3564 264 to 34   fully sequenced, AAA   231/231
(100 %)
0 diff
(100 %id)
AA933724 pooled germ cell tumors .k-u 3388 to 3572 200 to 16   AAA   185/185
(100 %)
1 diff
(99.5 %id)
AI088324 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 3390 to 3572 183 to 1       183/183
(100 %)
0 diff
(100 %id)
DA644658   .l-u 1 to 581 2 to 582   tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
AI697430 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1 to 467 467 to 1 exact tiling clone,   467/467
(100 %)
11 diff
(97.7 %id)
AI567419 anaplastic oligodendroglioma, brain .n 1 to 449 506 to 61 exact tiling clone,   446/506
(88 %)
0 diff
(100 %id)
R70601 placenta Gene DFFA, variant not shown         This clone was ignored    
AW993097 breast_normal Gene DFFA, variant not shown         Submitted on the opposite strand    
BX353048 Neuroblastoma Cot 10-normalized Gene DFFA, variant not shown         This clone was ignored    
BX374636 Neuroblastoma Cot 10-normalized Gene DFFA, variant not shown         This clone was ignored    
BX405199 T cells (Jurkat cell line) Gene DFFA, variant not shown         This clone was ignored    
BX405200 T cells (Jurkat cell line) Gene DFFA, variant not shown         This clone was ignored    
BX507767   Gene DFFA, variant not shown         Submitted on the opposite strand    
DB360214 whole embryo, mainly body Gene DFFA, variant not shown         This clone was ignored    
AU121243 whole embryo, mainly body Gene DFFA, variant not shown         This clone was ignored    
AA708336 pineal gland Gene DFFA, variant not shown         This clone was ignored    
AI127831 uterus Gene DFFA, variant not shown         This clone was ignored    
BE257290 eye, retinoblastoma Gene DFFA, variant not shown         This clone was ignored    
BE542896 cervix Gene DFFA, variant not shown         This clone was ignored    
BF032860 adenocarcinoma, ovary Gene DFFA, variant not shown         This clone was ignored    
BE740774 adenocarcinoma cell line, ovary Gene DFFA, variant not shown         This clone was ignored    
BG025421 lymph, lymphoma, cell line Gene DFFA, variant not shown         This clone was ignored    
BI861874 breast, mammary adenocarcinoma, cell line Gene DFFA, variant not shown         This clone was ignored    
BM911661 amelanotic melanoma, cell line, skin Gene DFFA, variant not shown         This clone was ignored    
BM912506 amelanotic melanoma, cell line, skin Gene DFFA, variant not shown         This clone was ignored    
BM423406 amelanotic melanoma, cell line, skin Gene DFFA, variant not shown         This clone was ignored    
BU158412 embryonal carcinoma, cell line, testis Gene DFFA, variant not shown              
BU171906 melanotic melanoma, skin Gene DFFA, variant not shown         This clone was ignored    
BU508269 leiomyosarcoma, uterus Gene DFFA, variant not shown       AAA This clone was ignored    
CX166933 human embryonic stem cells differentiated toan early endodermal cell type Gene DFFA, variant not shown         This clone was ignored    
CX753925 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass Gene DFFA, variant not shown         Submitted on the opposite strand    
TI_57193365   Gene DFFA, variant not shown         This clone was ignored    
DB229936 trachea Gene DFFA, variant not shown       capped This clone was ignored    
DB349950 trachea Gene DFFA, variant not shown         This clone was ignored    
CA419640 Bone, Human Chondrosarcoma Cell Line Gene DFFA, variant not shown       AAA This clone was ignored    
CA748798 Alveolar Macrophage, lung Gene DFFA, variant not shown         Suspected internal deletion, this clone was ignored    
BJ997825 Wilms tumor Gene DFFA, variant not shown         Suspected internal deletion, this clone was ignored    
BJ997826 Wilms tumor Gene DFFA, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI